ANTI-INFLAMMATORY EFFECT OF TRANSFORMING GROWTH FACTOR-??1 IN MYOBLAST TRANSPLANTATION1
Authors:
- 27 March 1998
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 65 (6) , 793-799
Abstract
Background. The inflammatory reaction that occurs during the 5 days after transplantation led at 3 days to the death of 70% of injected myoblasts. Use of anti-inflammatory agents appeared to be a possible way to increase myoblast survival. The application of gene transfer techniques to cell transplantation offers the potential for the prevention of inflammatory reaction. Methods. In this study, transforming growth factor-β1 (TGF-β1) gene was introduced in myoblasts with a retroviral vector to permit the secretion of this anti-inflammatory cytokine. Survival of (1) infected myoblasts expressing TGF-β1 or (2) normal myoblasts transplanted with genetically modified cloned myoblasts was compared with survival of normal myoblasts. Results. Expression of TGF-β1 by myoblasts or by cotransplanted cells decreased myoblast mortality after 3 days by roughly 20% (66.0±3.0% in control vs. 46.3±4.2% and 46.2±5.9%). The increase of myoblast survival by TGF-β1 expression was correlated with a lower polymorphonuclear cell and macrophage infiltration in muscles compared with control. In addition, cytotoxicity of neutrophils against myoblasts was assayed in vitro. The oxidation of myoblasts by activated neutrophils was decreased after infection of the myoblasts with the TGF-β1 retroviral vector. Conclusions. These data demonstrate that the insertion of TGF-β1 decreases inflammatory reaction observed after myoblast transplantation and thus prolongs their survival.Keywords
This publication has 29 references indexed in Scilit:
- Rapid death of injected myoblasts in myoblast transfer therapyMuscle & Nerve, 1996
- Successful histocompatible myoblast transplantation in dystrophin-deficient mdx mouse despite the production of antibodies against dystrophin.Journal of Cell Biology, 1995
- Pretreatment of myoblast cultures with basic fibroblast growth factor increases the efficacy of their transplantation in mdx miceMuscle & Nerve, 1995
- Very efficient myoblast allotransplantation in mice under FK506 immunosuppressionMuscle & Nerve, 1994
- Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantationMuscle & Nerve, 1994
- Gene Transfer into Skeletal Muscles by Isogenic MyoblastsHuman Gene Therapy, 1994
- High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice.Journal of Clinical Investigation, 1994
- Results of a Triple Blind Clinical Study of Myoblast Transplantations without Immunosuppressive Treatment in Young Boys with Duchenne Muscular DystrophyCell Transplantation, 1993
- Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophyNeuromuscular Disorders, 1993
- Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblastsNature, 1989